470 related articles for article (PubMed ID: 23418597)
21. Gene expression profiling of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathways.
Kato H; Karube K; Yamamoto K; Takizawa J; Tsuzuki S; Yatabe Y; Kanda T; Katayama M; Ozawa Y; Ishitsuka K; Okamoto M; Kinoshita T; Ohshima K; Nakamura S; Morishima Y; Seto M
Cancer Sci; 2014 May; 105(5):537-44. PubMed ID: 24581222
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
[TBL] [Abstract][Full Text] [Related]
24. The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7.
Ning S; Pagano JS
J Virol; 2010 Jun; 84(12):6130-8. PubMed ID: 20392859
[TBL] [Abstract][Full Text] [Related]
25. p52 Activation in monomorphic B-cell posttransplant lymphoproliferative disorder/diffuse large B-cell lymphoma without BAFF-R expression.
Proust A; Rincé P; Creidy R; Lazure T; Joab I; Garçon L; Fabre M; Guettier C; Raphael M
Am J Pathol; 2011 Oct; 179(4):1630-7. PubMed ID: 21871426
[TBL] [Abstract][Full Text] [Related]
26. EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells.
Boccellato F; Anastasiadou E; Rosato P; Kempkes B; Frati L; Faggioni A; Trivedi P
J Virol; 2007 Mar; 81(5):2274-82. PubMed ID: 17151114
[TBL] [Abstract][Full Text] [Related]
27. Enhanced PD-L1 Expression in LMP1-positive Cells of Epstein-Barr Virus-associated Malignant Lymphomas and Lymphoproliferative Disorders: A Single-cell Resolution Analysis With Multiplex Fluorescence Immunohistochemistry and In Situ Hybridization.
Kume A; Shinozaki-Ushiku A; Kunita A; Kondo A; Ushiku T
Am J Surg Pathol; 2022 Oct; 46(10):1386-1396. PubMed ID: 35605962
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus-associated primary central nervous system lymphomas in immunocompetent elderly patients: analysis for latent membrane protein-1 oncogene deletion and EBNA-2 strain typing.
Sugita Y; Terasaki M; Niino D; Ohshima K; Fumiko A; Shigemori M; Sato Y; Asano N
J Neurooncol; 2010 Nov; 100(2):271-9. PubMed ID: 20455004
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
30. Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas.
Mundo L; Del Porro L; Granai M; Siciliano MC; Mancini V; Santi R; Marcar L; Vrzalikova K; Vergoni F; Di Stefano G; Schiavoni G; Segreto G; Onyango N; Nyagol JA; Amato T; Bellan C; Anagnostopoulos I; Falini B; Leoncini L; Tiacci E; Lazzi S
Mod Pathol; 2020 Dec; 33(12):2407-2421. PubMed ID: 32483241
[TBL] [Abstract][Full Text] [Related]
31. Frequent downregulation of BTB and CNC homology 2 expression in Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Noujima-Harada M; Takata K; Miyata-Takata T; Sakurai H; Igarashi K; Ito E; Nagakita K; Taniguchi K; Ohnishi N; Omote S; Tabata T; Sato Y; Yoshino T
Cancer Sci; 2017 May; 108(5):1071-1079. PubMed ID: 28256087
[TBL] [Abstract][Full Text] [Related]
32. Lymphomas of the oral soft tissues are not preferentially associated with latent or replicative Epstein-Barr virus.
Gulley ML; Sargeant KP; Grider DJ; Eagan PA; Davey DD; Damm DD; Robinson RA; Vandersteen DP; McGuff HS; Banks PM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Oct; 80(4):425-31. PubMed ID: 8521106
[TBL] [Abstract][Full Text] [Related]
33. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
[TBL] [Abstract][Full Text] [Related]
34. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.
Novak U; Rinaldi A; Kwee I; Nandula SV; Rancoita PM; Compagno M; Cerri M; Rossi D; Murty VV; Zucca E; Gaidano G; Dalla-Favera R; Pasqualucci L; Bhagat G; Bertoni F
Blood; 2009 May; 113(20):4918-21. PubMed ID: 19258598
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders.
Ejima-Yamada K; Oshiro Y; Okamura S; Fujisaki T; Mihashi Y; Tamura K; Fukushige T; Kojima M; Shibuya K; Takeshita M
Virchows Arch; 2017 Feb; 470(2):205-215. PubMed ID: 27864689
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus infection and its gene expression in gastric lymphoma of mucosa-associated lymphoid tissue.
Xu WS; Chan AC; Lee JM; Liang RH; Ho FC; Srivastava G
J Med Virol; 1998 Dec; 56(4):342-50. PubMed ID: 9829640
[TBL] [Abstract][Full Text] [Related]
37. Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment.
Shields DJ; Byrd JC; Abbondanzo SL; Lichy JH; Diehl LF; Aguilera NI
Mod Pathol; 1997 Nov; 10(11):1151-9. PubMed ID: 9388067
[TBL] [Abstract][Full Text] [Related]
38. Mutation analysis of tumor necrosis factor alpha-induced protein 3 gene in Hodgkin lymphoma.
Etzel BM; Gerth M; Chen Y; Wünsche E; Facklam T; Beck JF; Guntinas-Lichius O; Petersen I
Pathol Res Pract; 2017 Mar; 213(3):256-260. PubMed ID: 28189285
[TBL] [Abstract][Full Text] [Related]
39. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study.
Carbone A; Dolcetti R; Gloghini A; Maestro R; Vaccher E; di Luca D; Tirelli U; Boiocchi M
Hum Pathol; 1996 Feb; 27(2):133-46. PubMed ID: 8617454
[TBL] [Abstract][Full Text] [Related]
40. Lymphoproliferative disorders in autoimmune diseases in Japan: analysis of clinicopathological features and Epstein-Barr virus infection.
Hoshida Y; Tomita Y; Zhiming D; Yamauchi A; Nakatsuka S; Kurasono Y; Arima Y; Tsudo M; Shintaku M; Aozasa K
Int J Cancer; 2004 Jan; 108(3):443-9. PubMed ID: 14648712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]